PD-L1 expression as a potential predictive biomarker
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference10 articles.
1. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015
2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015
3. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015
4. Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001;Daud;Proc Am Soc Clin Oncol,2015
5. Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous (non-SQ) cell non-small cell lung cancer (NSCLC);Paz-Ares;Proc Am Soc Clin Oncol,2015
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic and predictive role of immune microenvironment in colorectal cancer;World Journal of Gastrointestinal Oncology;2024-03-15
2. Prognostic value of body composition on survival outcomes in melanoma patients receiving immunotherapy;Frontiers in Immunology;2023-11-22
3. The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective;Frontiers in Immunology;2023-09-11
4. High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms;Hematology, Transfusion and Cell Therapy;2023-06
5. Combination of STAT3 inhibitor with Herceptin reduced immune checkpoints expression and provoked anti‐breast cancer immunity: An in vitro study;Scandinavian Journal of Immunology;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3